Medtronic (MDT) Stock Forecast & Price Target

Medtronic
Bull Case

Here are some ways that investors could benefit from investing in Medtronic plc:

• Medtronic plc recently announced a $700 million strategic partnership with Cornerstone Robotics to distribute the Sentire surgical system alongside its proprietary Hugo robotic-assisted surgery system in Europe, China, and Singapore, positioning the company to capture growth in the rapidly expanding medical robotics market which is projected to grow from $20.6 billion in 2026 to $41.7 billion by 2031.
• The company demonstrated strong financial performance in its most recent quarter, reporting earnings per share of $1.45 which beat analyst estimates of $1.39, while revenue reached $9.76 billion, exceeding expectations of $9.55 billion and representing a 13.7% year-over-year increase, indicating accelerating growth momentum.
• Medtronic plc offers a compelling income opportunity with a current dividend yield of 3.25%, supported by a recent quarterly dividend announcement of $0.72 per share payable on October 16th, which provides a steady cash flow for income-focused investors.
• Analysts maintain a Moderate Buy consensus rating with a price target of $103.92, suggesting significant upside potential from the current stock price of $88.47, as the stock is trading well below its 52-week high of $106.33 and near its 52-week low of $73.31.
• The company has a low beta of 0.56, indicating that its stock price is less volatile than the broader market, which may appeal to risk-averse investors seeking stability in their healthcare portfolio holdings.